Form 4: Cabot Corp CEO Sean Keohane Exercises Options and Sells Shares
SEC Form 4 Filing
Sean Keohane, President and CEO of Cabot Corporation, exercised stock options and sold shares on September 3, 2024.
Summary
- On September 3, 2024, Sean D. Keohane, the President and CEO of Cabot Corporation, exercised employee stock options to acquire 25,617 shares of common stock at a price of $39.54 per share.
- Following the exercise of the options, Keohane sold 17,865 shares at a weighted average price of $101.2321 and 7,752 shares at a weighted average price of $102.2777.
- After these transactions, Keohane directly owns 331,174 shares of Cabot Corporation common stock and indirectly owns 13,561.02 shares through the Corporation's 401(k) Plan.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a broader trend in the specialty chemicals industry. However, monitoring insider activity can provide insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Insider trading activity is common across publicly listed companies.
- Comparing Keohane's transactions to those of executives at similar companies like Dow or DuPont would provide a better benchmark.
- Form 4 filings are a standard part of regulatory compliance for corporate insiders.
Stakeholder Impact
- The transactions may have a minor impact on shareholders, potentially influencing short-term stock price fluctuations.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 11/12/2016 | 30% of the employee stock options vested. |
| 11/12/2017 | 30% of the employee stock options vested. |
| 11/12/2018 | 40% of the employee stock options vested. |
| 09/03/2024 | Sean Keohane exercised stock options and sold shares. |
| 09/04/2024 | Date of the signature on the Form 4 filing. |
| 11/11/2025 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.